Background
==========

Currently, the only curative treatment of end-stage heart failure is heart transplantation. However, due to strict transplantation regulations and lack of public awareness, shortage of transplantable organs persists worldwide, and waiting list mortality is still unacceptably high \[[@b1-medscimonit-23-2232],[@b2-medscimonit-23-2232]\]. The human heart lacks the ability to regenerate after tissue necrosis. Although many advances have been made in the development stem cell-based regeneration therapy, a number of unsolved problems have yet to be resolved \[[@b3-medscimonit-23-2232]\]. Loss of contractile cardiomyocytes leads to decrease in myocardial pump function and symptomatic heart failure. Tissue engineering has been applied in research to treat heart failure and localized myocardial necrosis with the construction of beating myocardial patches \[[@b4-medscimonit-23-2232]\]. Whole-heart tissue engineering programs have been created to circumvent the worldwide shortage of organs for transplantation. Whole-heart decellularization by organ perfusion has already been described in porcine \[[@b5-medscimonit-23-2232],[@b6-medscimonit-23-2232]\] and rat \[[@b7-medscimonit-23-2232]\] hearts. After perfusion decellularization, an intact, cell-free, 3-dimensional (3D) heart scaffold remains, consisting of extracellular matrix components, which allows recellularization with human cells: cardiomyocytes, endothelial cells, or other cell types. In 3D organ tissue engineering research, besides constructing suitable scaffolds, finding appropriate cellular compounds is a key part of the process \[[@b8-medscimonit-23-2232]\]. Potential usage of organ recellularization is discussed frequently \[[@b9-medscimonit-23-2232]--[@b12-medscimonit-23-2232]\] as a successful clinical translation that could represent a new era in heart failure therapy.

Tissue engineering research exhibits a variety of approaches. Arshi et al. focused on the effect of matrix rigidity on cardiac differentiation using human and murine embryonic stem cells with the intention to manipulate proliferation of functional cardiomyocytes \[[@b13-medscimonit-23-2232]\]. For patch implantation, different methods have also been described. Besides research on tissue engineering, an artificial tissue substitute consisting of poly(ɛ-caprolactone) (PCL) and poly(ethylene glycol) (PEG) has also been developed \[[@b14-medscimonit-23-2232]\].

Research on the components of extracellular matrix (ECM) has been progressing for decades. Seif-Naraghi et al. used a pericardial matrix in heart surgery for septal reconstruction in congenital atrial septum defects, consisting of collagen type I, V, and VIII. In addition, elastin and fibrillin were retained in all samples. In a few experiments, collagen type III and IV, as well as microfibrillar-associated protein 4 (MFAP4) and procollagen type I, were recorded with tandem mass spectrometry \[[@b15-medscimonit-23-2232]\]. Badylak \[[@b16-medscimonit-23-2232]\] reported that growth factors, fibronectin, laminin, and glycosaminoglycans were measured as ECM components. Fibronectin had an even greater role in the embryological phase.

Fibronectin is a dimeric, high-molecular weight molecule that is rich in Arg-Gly-Asp (RGD) sequence. Soluble and tissue isoforms have been identified. Cell adhesion facilitating capabilities of fibronectin have been described \[[@b17-medscimonit-23-2232],[@b18-medscimonit-23-2232]\]. Fibronectin is mainly located in submucosal structures and basement membranes. Because of its adhesive properties, fibronectin is often used to enable biocompatibility \[[@b19-medscimonit-23-2232]\]. The RGD amino acid sequence is important in cell adhesions through α~5~β~1~ integrin, playing the main role in cell-cell and cell-matrix adhesion \[[@b18-medscimonit-23-2232]\].

The basics of impedimetry applied to cellular systems were developed by Giaever and Keese \[[@b20-medscimonit-23-2232]\], and their electric cell-substrate impedance sensing (ECIS) system was the starting equipment in the field. A great advantage of these cell physiological recordings is their real-time character, which provides even longer tracking periods. For high-sensitivity monitoring of cell adhesion, the xCELLigence system has been developed \[[@b19-medscimonit-23-2232],[@b21-medscimonit-23-2232]\]. The xCELLigence SP device measures impedance changes on network of gold electrodes caused by adhering cells, allowing label-free assessment of cell adhesion and non-invasive measurements of cell impedances alterations. The measured impedance depends on the number of adhering cells, as well as the level and type of adhesion.

Our aims in the present study were: (i) to characterize the effect of decellularized porcine heart scaffold homogenates on cell adhesion of human cells (cardiomyocytes and endothelial cells) used as the chief constituents of recellularization; and (ii) to investigate cell-ECM element interactions as guiding processes in development of artificial multi-layer systems -- cellular models of recellularization of heart scaffolds.

Material and Methods
====================

Cell culture
------------

We performed experiments with fibrosarcoma, endothelial cells, and cardiomyocytes. HT-1080 human connective tissue-derived fibrosarcoma cell line (ATCC, Manassas, VA) was cultured in Minimum Essential Medium (ATCC, Manassas, VA) and 10% fetal calf serum (FCS). HMEC-1 human dermal microvascular endothelial cells (Invitrogen, Life Technologies, Carlsbad, CA) were cultured in MCDB-131 (Sigma Ltd. St. Louis, MO), 10% FCS (Lonza Group Ltd. Basel, Switzerland), L-glutamine (4 mmol/mL) (Gibco^®^/Invitrogen Corporation, NY), penicillin/streptomycin (100 I.U./mL, 100 μg/mL) (Gibco^®^/Invitrogen Corporation, NY), human recombinant epidermal growth factor (10 ng/ml) (Sigma, Ltd., St. Louis, MO), and hydrocortisone (1 μg/mL) (Sigma, Ltd.). HCM primary human cardiac myocytes (PromoCell, Biomedica, Wien, Austria) were cultured in Myocyte Growth Medium (PromoCell, Biomedica).

Decellularized porcine heart scaffold
-------------------------------------

Decellularized porcine heart scaffold was produced by perfusion technique as previously described by Weymann et al. \[[@b5-medscimonit-23-2232]\]. Briefly, the hearts were perfused through the aorta in a perfusion circuit containing a pressure control module and a heat exchanger. The hearts were perfused on a constant pressure of 100 Hgmm and temperature of 37°C with a 4% solution of sodium dodecyl sulfate in PBS (phosphate buffer solution) at 2 L/min for 12 h. Every 3 h, the hearts were washed with PBS for 15 min. After 12 h of perfusion, the hearts were washed with PBS at 1.5 L/min for 24 h. For our experiments, an approximately 1-cm^3^ patch of the heart scaffold's apex was obtained and homogenized by an ultrasound-based approach (pulse mode, 25 pulse/min, amplitude=60, tune=50, Vibra Cell VC40, Sonics & Materials Inc., USA), after which the sample was suspended in distilled water.

Impedimetry measurements
------------------------

For measurement of cell adhesion, we used the xCELLigence SP (Roche Applied Science, Indianapolis, IN) system, which uses an impedance-based approach. In this technique adhesion surfaces are intricate gold microelectrode arrays placed at the bottom of 96-well of E-plates, covering about 80% of each well \[[@b22-medscimonit-23-2232],[@b23-medscimonit-23-2232]\]. Adhering cells generate changes in electric impedance measured on the electrode, which directly correlate to surface coverage by cells, as determined by 2 factors: (i) the number of adhering cells and (ii) the spreading of individual cells \[[@b21-medscimonit-23-2232]\]. Impedance changes are monitored in real-time.

Data are expressed in the form of Cell Index (CI), a dimensionless value calculated from impedance measured at a given time point (Z~t~), background impedance (Z~b~), and a in-built factor depending on the frequency of the alternating current (F) according to the following formula \[[@b24-medscimonit-23-2232]\]:
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The advantage of this technique is automated continuous measurement and label-free detection. We used real-time monitoring RTCA Software version 1.2.0.0909 and an Analyzer model W380.

Single-cell layout experiments
------------------------------

The bottoms of the wells were coated with either 25 μL of: (a) heart scaffold homogenate (HS), (b) fibronectin (Human Plasma Fibronectin Purified Protein, Merck, Whitehouse Station, NJ) diluted in distilled water to an end concentration of 16 μg/mL (FN), (c) a compound of fibronectin and heart scaffold homogenate (fibronectin diluted in heart scaffold homogenate to an end concentration of 16 μg/mL) (FN + HS), or (d) distilled water (Control). After 30 min of incubation in room temperature, the remaining solution was gently aspirated and the electrodes were air dried. For the measurement of baseline, 100 μL of medium (according to each cell line) was added to the wells and incubated for 1 h at 37°C and 5% CO~2~. After the measurement of baseline impedance, 100 uL of cell suspension was added to the wells and changes in impedance were recorded for 72 h at 37°C and 5% CO~2~ incubation. Three different cell densities were measured each cell line (10 000/well, 15 000/well, and 20 000/well for HT-1080 fibrosarcoma cells and HMEC-1 endothelial cells, and 5000/well, 10 000/well, and 15 000/well for HCM cardiomyocytes). In each sample, 4 parallels were measured ([Figure 1](#f1-medscimonit-23-2232){ref-type="fig"}).

"Sandwich" layout experiment
----------------------------

We added 100 μL medium to the wells, and baseline impedance was measured for 1 h at 37°C and 5% CO~2~ incubation. After that, 100 μL HMEC-1 cell suspension (cell count 20 000/well) was added to the wells and incubated for 24 h (37°C and 5% CO~2~) until an endothelial monolayer was formed, as confirmed by impedimetry curves reaching plateau phase. Then, 100 μL of medium was gently aspirated and replaced with 100 μL of either HS, FN, or FN + HS treatment solution as described in the previous section. In the control wells, no treatment solution was added (Control), and incubated for 30 min at 37°C and 5% CO~2~. Subsequently, 100 μL solution was gently aspirated and 150 μL cardiomyocyte suspension was added to the wells in 5000/well, 10 000/well, and 15 000/well cell densities. After that, impedance changes were recorded for 72 h at 37°C and 5% CO~2~ incubation. In each sample, 4 parallels were measured ([Figure 1](#f1-medscimonit-23-2232){ref-type="fig"}).

Statistical analysis
--------------------

Cell adhesion was quantified as slope values (the rise of a line laid on a defined interval of the curve) (1/h) as calculated by RTCA software. In every experiment, 2 slope values depicting short-term and long-term adhesion activity were analyzed (as given below). For statistical analysis, one-way ANOVA was used. For marking the level of significance, the following symbols were used: x -- p\<0.05, y -- p\<0.01 and z -- p\<0.001. In graphical representation of impedimetry data curves, the Delta Cell Index is shown, and the zero point is the first measured data point for the examined cell line in the well.

Results
=======

In cell adhesion experiments, calculation of slope values provides one of the best opportunities to evaluate dynamics of cell adhesion in short- and long-term experiments, as well as to compare responsiveness of identical experimental schedules. Our pilot experiments in all 4 types of model cells showed that completion of adhesive processes is rather different. In the short-term, it lasts from 1: 09 to 2: 25 h, while in the long-term it lasts from 16 to 40 h. These data show good correlation with the cell physiology, as short-term experiments describe the rapid adhesion of the cells, while the long-term adhesion experiments investigated how the initial adhesion continues to spread or other time-consuming cellular processes (e.g., micromotion and haptotaxis).

In the data presented below, values of slope calculated by RTCA (for details see 2.4) are given to characterize effects of the substances investigated. The calculated slope values approximate the rise or fall of specific intervals, and, as such, they are relative values and can vary between experiments, cell types, and different time ranges. Trends, direction of change, and rough measure of effect are comparable between experiments, but exact values are not. Consequently, graphs below showing slope values do not have the same scales. All time values and intervals are given in Delta Time, where zero point is chosen as the first measurement point after addition of the measured cells (cardiomyocytes in the "sandwich" experiment. In the text, time intervals are shown in 'TI: hh: mm' format.

Short-term effects
------------------

### Fibrosarcoma cell line (HT-1080) (TI: 0:00--1:21)

HT-1080 cells showed strong adhesion activity that was not influenced by the HS at any cell density (10 000/well -- Control 0.492±0.012 *vs.* HS 0.514±0.034; 15 000/well -- Control 0.721±0.029 *vs.* HS 0.634±0.040; 20 000/well -- Control 0.900±0.057 *vs.* HS 0.831±0.037). In contrast HS, fibronectin (FN) increased cell adhesion significantly in all the examined cell densities (10 000/well -- FN 0.923±0.044, p\<0.001; 15 000/well -- FN 1.267±0.137, p=0.01; 20 000/well -- FN 1.591±0.233, p=0.05). The combination of fibronectin and heart scaffold homogenate (FN+HS) also had a significant adhesion-inducer activity in every tested cell density (10 000/well -- FN + HS 0.925±0.083, p=0.01; 15 000/well -- FN + HS 1.309±0.203, p=0.05; 20 000/well -- FN + HS 1.545±0.162, p=0.01). The inducer effects elicited by fibronectin alone and in combination with fibronectin showed no significant difference ([Figure 2A](#f2-medscimonit-23-2232){ref-type="fig"}).

### Human microvascular endothelial cell line (HMEC-1) (TI: 0:00--2:25)

HMEC-1, similarly to fibrosarcoma cells, expressed strong adhesion that was not changed by HS applied in different cell densities (10 000/well -- Control 0.369±0.016 *vs.* HS 0.347±0.019, 15 000/well -- Control 0.581±0.031 *vs.* HS 0.520±0.032; 20 000/well -- Control 0.856±0.080 *vs.* HS 0.780±0.042). FN increased adhesion significantly in 10 000/well and 15 000/well cell densities (10 000/well -- FN 0.473±0.033, p=0.05 and 15 000/well -- FN 0.770±0.056, p=0.05) and tendentially in 20 000/well cell density (20 000/well -- FN 1.298±0.164). Combination of FN and HS increased adhesion tendentially in 10 000/well cell density (10,000/well -- FN + HS 0.431±0.030) and significantly on 2 higher cell densities (15 000/well -- FN + HS 0.772±0.040, p=0.01 and 20 000/well -- FN + HS 1.263±0.138, p=0.05). No significant difference was observed between the positive effect of FN in combination with HS and responses elicited by FN alone ([Figure 2C](#f2-medscimonit-23-2232){ref-type="fig"}).

### HCM human cardiomyocyte cell line (TI: 00:05--01:09)

HCM cardiac cells showed good adhesion behavior that was not changed by HS at any cell density (5000/well -- Control 0.368±0.016 *vs.* HS 0.390±0.025, 10 000/well -- Control 0.571±0.009 *vs.* HS 0.613±0.031 and 15 000/well -- Control 0.724±0.025 *vs.* HS 0.640±0.022). FN significantly increased cell adhesion at all cell densities (5000/well -- FN 0.627±0.010, p\<0.001, 10 000/well -- FN 1.032±0.082, p=0.05 and 15 000/well -- FN 1.394±0.021, p\<0.001). The combination of FN and HS increased cell adhesion significantly in 5000/well cell count (5000/well -- FN + HS 0.731±0.026, p\<0.001) and tendentially in the 2 higher cell densities (10 000/well -- FN + HS 2.035±0.630; 15 000/well -- FN + HS 2.278±0.583). The positive effect of FN applied alone was significantly enhanced in combination with HS at 5000/well cell density (FN 0.627±0.010 *vs.* FN + HS 0.731±0.026, p=0.05) and a tendentially increased effect was registered in the 2 higher cell counts (10 000/well -- FN 1.032±0.082 *vs.* FN + HS 2.035±0.630 and 15 000/well -- FN 1.394±0.021 *vs.* FN + HS 2.278±0.583) ([Figure 2E](#f2-medscimonit-23-2232){ref-type="fig"}, [Figure 3A](#f3-medscimonit-23-2232){ref-type="fig"}).

### "Sandwich" layout (endothelial and cardiomyocyte) (TI: 00:00--00:23)

In short-term experiments, cardiomyocytes adhered strongly to the endothelial cell layer in all cardiomyocyte cell densities and was significantly increased by HS treatment (5000/well -- Control 1.815±0.043 *vs.* HS 6.104±0.192, p\<0.001, 10 000/well -- Control 1.943±0.019 *vs.* HS 5.774±0.506, p\<0.001 and 15 000/well -- Control 1.794±0.120 *vs.* HS 6.048±0.299, p\<0.001). FN increased significantly adhesion at all cell densities as well (5000/well -- FN 6.215±0.095, p\<0.001, 10 000/well -- FN 6.107±0.520, p\<0.001 and 15 000/well -- FN 6.001±0.258, p\<0.001). The combination of FN and HS increased significantly adhesion at all cell counts as well (5000/well -- FN + HS 6.006±0.115, p\<0.001, 10 000/well -- FN + HS 6.391±0.208, p \< 0.001 and 15 000/well -- FN + HS 6.297±0.344, p\<0.001). Adhesion-inducer effects of FN and HS applied alone or in combination showed no difference in volume or dynamics of HCM cell adhesion ([Figure 3B](#f3-medscimonit-23-2232){ref-type="fig"}, [Figure 4A](#f4-medscimonit-23-2232){ref-type="fig"}).

Long-term effects
-----------------

### HT-1080 fibrosarcoma cell line (TI: 2:54--31:00)

In long-term experiments, we found no significant change of the aforementioned effects, and in 10 000/well cell density, the positive effect of FN was significantly increased (10 000/well -- Control 0.063±0.002 *vs.* FN 0.085±0.004, p=0.01), similar to the positive effect of FN + HS (10 000/well -- Control 0.063±0.002 *vs.* FN + HS 0.092±0.011, p=0.05) ([Figure 2B](#f2-medscimonit-23-2232){ref-type="fig"}).

### HMEC-1 human microvascular endothelial cell line (TI: 07:06--47:45)

At 10 000/well cell density, HS increased adhesion slightly but significantly (10 000/well -- Control 0.020±0.0004 *vs.* HS 0.021±0.0001, p=0.05). The effect of FN alone and the combination of FN + HS was significantly increased (10 000/well -- FN 0.029±0.003, p=0.05 and FN + HS 0.033±0.003, p=0.01). At 15 000/well cell density, a weak but significantly decreased adhesion was observed with HS (15 000/well -- Control 0.035±0.001 *vs.* HS 0.029±0.001, p=0.05), but with FN alone and in FN +HS combination, only positive tendencies (15 000/well -- FN 0.040±0.006 and FN + HS 0.048±0.009) were registered. At 20,000/well cell density, FN had a significant adhesion-decreasing effect (20 000/well -- Control 0.048±0.003 *vs.* FN 0.034±0.003, p=0.05), which was completely counteracted in the combination FN + HS (20 000/well FN + HS 0.048±0.005, p=0.05) ([Figure 2D](#f2-medscimonit-23-2232){ref-type="fig"}).

### HCM human cardiomyocyte cell line (TI: 07:52--24:00)

In the long-term experiment, a backlash of the positive short-term adhesion was found. Compared to Control, responses were significantly stronger in FN alone in 5000/well and 15 000/well cell densities (5000/well -- Control 0.004±0.001 *vs.* FN -0.001±0.0004, p=0.05 and 15 000/well -- Control −0.008±0.002 *vs.* FN −0.021±0.002, p=0.01), and in combinations FN + HS in 10 000/well and 15 000/well cell densities (10 000/well -- Control −0.004±0.002 *vs.* FN + HS −0.040±0.012, p=0.05 and 15 000/well -- Control −0.008±0.002 *vs.* FN + HS −0.043±0.009, p=0.05) ([Figure 2F](#f2-medscimonit-23-2232){ref-type="fig"}, [Figure 3A](#f3-medscimonit-23-2232){ref-type="fig"}).

### "Sandwich" layout of endothelins and cardiomyocytes (TI: 17:01--66:00)

At 15 000/well cell density, the adhesion was significantly enhanced by HS alone (15 000/well -- Control 0.061±0.003 *vs.* HS 0.070±0.002, p=0.05) and also in combination with FN (15 000/well -- Control 0.061±0.003 *vs.* FN + HS 0.081±0.006, p=0.05) ([Figure 3B](#f3-medscimonit-23-2232){ref-type="fig"}, [Figure 4B](#f4-medscimonit-23-2232){ref-type="fig"}).

Discussion
==========

In the last decade great strides have been made towards the construction of a tissue-engineered whole heart; however, unsolved challenges still remain, particularly in recellularization of decellularized, whole-organ scaffolds \[[@b25-medscimonit-23-2232]\]. Endothelialization of human pulmonary and aortic valve grafts has been described \[[@b26-medscimonit-23-2232]\], but recellularization of 3D myocardial scaffolds with cardiomyocytes has only been achieved in thin myocardial patches with low cell density \[[@b27-medscimonit-23-2232]\]. Advances have been made with re-cellularized rat heart, showing a fraction of adult contractile function \[[@b7-medscimonit-23-2232]\]; however, construction of a recellularized, functional whole heart is still a goal to be achieved.

For tissue engineering of human-sized whole hearts, cadaveric human hearts could constitute optimal scaffolds, but the scarcity of organ donors limits this option. Porcine hearts are easily obtainable from slaughterhouse pigs, and, after proper decellularization, cell-free, potentially immuno-neutral scaffolds can be produced \[[@b5-medscimonit-23-2232]\]. By recellularization with human cells and human regulatory molecules, an optimal, implantable whole-heart allograft could be achieved.

Cellular-level characterization of the adhesive properties of decellularized heart scaffolds and their relationship with human cells can provide valuable insight for future recellularization research. The HT-1080 human fibrosarcoma cell line is a tumor cell line with strong adhesive properties used, among others, as the model cell for adhesion studies \[[@b28-medscimonit-23-2232]\]. In our experiments with HT-1080 cells, characteristic cell density-dependent, strong adhesion profile was measured, which was further increased by fibronectin (FN) precoating. On porcine heart scaffold homogenate coating, a similarly strong adhesion of HT-1080 cells was measured and the positive effect of FN could be observed in this case as well. According to these results, decellularized heart scaffold has no adhesion-inhibiting effect *per se*. Endothelial cells are unique to the cardiovascular system that covers the luminal, vascular part of the endocardium. Characterization of the effect of porcine decellularized heart scaffold on the behavior of this essential part of cardiac anatomy can aid the development of a usable recellularization protocol. In our assessment, the adhesion activity of HMEC-1 endothelial cells was maintained on precoating with porcine decellularized heart scaffold (HS) homogenate with or without the addition of FN. Besides endothelial cells, cardiomyocytes are the other function-specific cell types essential to include in the whole-heart recellularization process. Therefore, it is necessary to characterize their reaction to decellularized heart scaffold. In our experiments, adhesion activity of HCM cardiomyocytes was not decreased by HS. Combined with FN coating, an enhancer effect was observed, especially at low cell densities (5000/well). Even though a decrease in this enhancement was observed in the long term, the initial level of adhesion persisted. At higher cell densities (10 000/well and 15 000/well), this decline was more strongly expressed, which suggests that technical factors, such as static experimental setup and no disruption of experiment with medium change, might also influence the development of this phenomenon. In the "sandwich" experimental layout, HS significantly increased cardiomyocyte adhesion to the preloaded and preseeded (24 h) confluent (signified by curves reaching plateau phase) endothelial layer, which shows the positive effect of FN. This strong positive effect proved to be constant through the whole period of the long-term measurement (72 h). These results establish that the decellularized porcine HS has a neutral or enhancer effect on human cardiovascular cells at the cellular adhesion level. In addition, our experiments show that HMEC-1 microvascular-origin endothelial cells and HCM cardiomyocytes are promising candidates for further recellularization experiments on tissue-engineered heart scaffolds.

Regardless of these encouraging results about the relationship between cardiovascular cells and decellularized heart scaffold, discovering potential regulator molecules for the recellularization process could provide substantial help. FN Fibronectin is a well-known enhancer and modifier of cell adhesion \[[@b18-medscimonit-23-2232]\]. Ott et al. reported the presence of FN in decellularized heart scaffold \[[@b7-medscimonit-23-2232]\]. In our experiment, FN treatment increased the positive effect of FN on adhesion of HT-1080 fibrosarcoma, HMEC-1 endothelial and HCM cardiomyocyte cell lines, and the cell-cell adhesion between endothelial cells and cardiomyocytes. Coating of decellularized aortic grafts with FN was shown to increase *in vivo* endothelialization of grafts in rats \[[@b24-medscimonit-23-2232]\]. Our experiments with porcine decellularized heart scaffold showed a similar enhancer effect of addition of FN + HS surface coating on adhesion of endothelial cells and even cardiomyocytes. Therefore, our present results support the proposal \[[@b24-medscimonit-23-2232]\] that FN could be employed as both an enhancer and regulator molecule in the recellularization process in heart engineering.

Conclusions
===========

Our experiment shows for the first time that real-time impedimetry assay is a strong de/recellularization model of cardiac heart scaffold. Decellularized porcine heart scaffold had neutral or enhancer effect on the adhesion of human endothelial cells and cardiomyocytes, while no inhibiting effect was observed. On the cellular level, decellularized porcine heart scaffold homogenates (HS) provided a compatible and attractive environment for human cardiovascular cells. Fibronectin elicited a strong positive effect on cell adhesion, so in the future this extracellular compound could be a valuable regulator and enhancer factor of the recellularization process. Consequently, homogenates of decellularized porcine heart scaffolds, as well as impedimetry, are good candidate systems to investigate recellularization as a part of research in whole-heart tissue engineering.
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![Experimental protocols. In the experiments, cells were investigated: (i) as single-cell layers on non-coated or on FN, HS, or FN+HS coated surfaces, and (ii) as "sandwich" cell combinations of ET and CM cell layers with or without interconnecting layer of FN, HS, or FN+HS. HS -- decellularized heart scaffold homogenate; FN -- fibronectin; FN + HS -- combination of fibronectin and decellularized heart scaffold homogenate; ET -- HMEC-1 human microvascular endothelial cell; CM -- HCM human cardiac myocytes.](medscimonit-23-2232-g001){#f1-medscimonit-23-2232}

![Impedimetric measurements -- Single-cell layout protocols. Effect of decellularized heart scaffold homogenate and fibronectin electrode coating on adhesion of fibrosarcoma (**A**: short-term, **B**: long-term), endothelial (**C**: short-term, **D**: long-term), and cardiomyocyte (**E**: short-term, **F**: long-term) cell lines. HS -- decellularized heart scaffold homogenate; FN -- fibronectin, FN + HS -- combination of fibronectin and decellularized heart scaffold homogenate; HT-1080 human fibrosarcoma cell line; HMEC-1 human microvascular endothelial cell line; HCM human cardiac myocytes; x: p\<0.05; y: p\<0.01; z: p\<0.001.](medscimonit-23-2232-g002){#f2-medscimonit-23-2232}

![Impedimetric detection of cell adhesion. Representative experiments showing effect of electrode coating on adhesion of HCM human cardiac myocytes (5000/well) (**A**) and effect of coating treatment on adhesion of HCM human cardiac myocytes (5000/well) to HMEC-1 human microvascular endothelial cell monolayer (20 000/well) (**B**).](medscimonit-23-2232-g003){#f3-medscimonit-23-2232}

![Impedimetric measurements -- "Sandwich" layout protocols. Effect of decellularized heart scaffold homogenate and fibronectin coating treatment on adhesion of cardiomyocyte cell line to endothelial cell monolayer (**A**: short-term, **B**: long-term). HS -- decellularized heart scaffold homogenate; FN -- fibronectin, FN + HS -- combination of fibronectin and decellularized heart scaffold homogenate; HMEC-1 human microvascular endothelial cell line; HCM human cardiac myocytes; x: p\<0.05; y: p\<0.01; z: p\<0.001.](medscimonit-23-2232-g004){#f4-medscimonit-23-2232}
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